MGNXCIK 1125345

MACROGENICS INC

EDGAR filings

Customers

3 active

Suppliers

None disclosed

Largest customer

33%

Sanofi S.A. · FY to 2025-12-31

Named-customer revenue

$97.2M

2 customers · FY to 2025-12-31

Latest period

Dec 31, 2025

10-K filed 2026-03-09

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available). Thin bands are named without a figure. Click a band to open its filing.

Customers 5

Companies MGNX discloses as major customers, as a share of MGNX revenue. 3 active, 2 lapsed.

Company	% of MGNX revenue	Est. revenue	Period	Trend	Status	Source
Sanofi S.A. Non-SEC Sanofi S.A.	33%	$49.3M	FY 2025-12-31	+23.0pp	Active	10-K 2026-03-09
Sanofi S.A. (Sanofi) 33 % * 10 % 10-K filed 2026-03-09 Period FY 2025-01-01 to 2025-12-31 (33%), FY 2023-01-01 to 2023-12-31 (10%)Accession 0001125345-26-000017
INCY INCYTE CORP	32%	$47.8M	FY 2025-12-31	−44.0pp	Active	10-K 2026-03-09
The following table includes those counterparties that represent more than 10% of total revenue earned in the periods indicated:Year Ended December 31,202520242023Sanofi S.A. (Sanofi)33%10%Incyte Corporation (Incyte)32%76%53%Gilead Sciences, Inc (Gilead)24%ASD Healthcare and Oncology Supply (ASD)10%McKesson Plasma & Biologics and McKesson Specialty Care Distribution LLC (McKesson)*12% 10-K filed 2026-03-09 Period FY 2025-01-01 to 2025-12-31 (32%), FY 2024-01-01 to 2024-12-31 (76%), FY 2023-01-01 to 2023-12-31 (53%)Accession 0001125345-26-000017
CAH Distributor CARDINAL HEALTH INC	Named	—	FY 2024-12-31	—	Lapsed Last seen 2024-12-31	10-K 2026-03-09
Cardinal Health, Inc. * 12 % 10-K filed 2026-03-09 Period FY 2024-01-01 to 2024-12-31Accession 0001125345-26-000017
EBS Emergent BioSolutions Inc.	Named	—	FY 2025-12-31	—	Active	10-K 2026-03-09
Emergent Biosolutions 16 % * 10-K filed 2026-03-09 Period FY 2025-01-01 to 2025-12-31Accession 0001125345-26-000017
McKesson Plasma & Biologics and McKesson Specialty Care Distribution LLC Non-SEC McKesson Plasma & Biologics and McKesson Specialty Care Distribution LLC	Named	—	FY 2024-12-31		Lapsed Last seen 2024-12-31	10-K 2026-03-09
The following table includes those counterparties that represent more than 10% of total revenue earned in the periods indicated:Year Ended December 31,202520242023Sanofi S.A. (Sanofi)33%10%Incyte Corporation (Incyte)32%76%53%Gilead Sciences, Inc (Gilead)24%ASD Healthcare and Oncology Supply (ASD)10%McKesson Plasma & Biologics and McKesson Specialty Care Distribution LLC (McKesson)*12% 10-K filed 2026-03-09 Period FY 2024-01-01 to 2024-12-31, FY 2023-01-01 to 2023-12-31 (12%)Accession 0001125345-26-000017

Alerts are coming

Get an email when MGNX's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.